arrow
M

MacLean P. Nasrallah

University of Pennsylvania
H指数:39
被引数:8,090

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Divergent genomic evolution in astrocytomas and oligodendrogliomas

星形胶质瘤和少突胶质瘤的基因组趋异进化

Nature
IF48.5
2026-10-140
OAAI
High-grade astrocytoma with piloid features: a clinical and genomic analysis of prognostic factors using a large cohort

伴毛细胞样特征的间变性星形细胞瘤:利用大型队列进行预后因素的临床和基因组学分析

2026-09-160
PRE
Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study

基于个性化机器学习指导的 Newly Diagnosed Glioblastoma 患者放射剂量递增:前瞻性试点研究

2026-05-130
OAAI
Immune remodeling in CSF and tumor predicts response to CAR T therapy in glioblastoma

脑脊液和肿瘤中的免疫重塑预测胶质母细胞瘤对CAR T疗法的反应

2025-11-010
OAAI
Growth rates of patient-derived tumor organoids reflect glioblastoma patients' heterogeneity in survival

患者来源的肿瘤类器官的生长速率反映了胶质母细胞瘤患者生存的异质性

2025-11-010
OAAI
Neuropath-IHC: a deep neural network for virtual immunohistochemistry from digital whole slide images of CNS tumors

神经病理-IHC:一种用于中枢神经系统肿瘤数字全切片图像虚拟免疫组化分析的深度神经网络

2025-11-010
OAAI
Unveiling glioblastoma heterogeneity with deep learning derived MRI subtyping: insights from the global ReSPOND consortium

利用深度学习衍生MRI亚型对胶质母细胞瘤异质性进行解析:全球ReSPOND联盟的见解

2025-11-010
OAAI
BraTS-Pathology 2024: Insights and Future Directions Informed by the AI-RANO & RANO-RGP Effort to Assess Glioblastoma Heterogeneity

BraTS-Pathology 2024:基于AI-RANO与RANO-RGP评估胶质母细胞瘤异质性的见解与未来方向

2025-11-010
OAAI
Neuropath-AI, a histopathology-based deep learning classifier for CNS tumors, achieves and improves human neuropathologist-level performance

Neuropath-AI,一种基于组织病理学的深度学习分类器,用于CNS肿瘤,实现了并提高了人类神经病理学家的水平。

2025-11-010
OAAI
Uncertainty-aware ensemble of foundation models differentiates glioblastoma from its mimics

不确定性感知的基础模型集成区分胶质母细胞瘤与其类似物

2025-09-290
OAAI
Pineal region high-grade neuroepithelial tumors with NTRK fusions map to the novel methylation class “diffuse high-grade glioma, IDH-wild type, subtype E”

松果体区高级别神经上皮性肿瘤伴NTRK融合映射到新型甲基化类“弥漫性高级别胶质瘤,IDH野生型,亚型E”。

2025-09-090
PRE
Intratumoral preservation of the stem-like malignant cell proportion in glioblastoma, prognostic impact, and its radiomethylomic signatures

胶质母细胞瘤中类干细胞恶性细胞比例的瘤内保存、预后影响及其放射甲基组学特征

2025-09-010
PRE
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial

Bagley SJ, Desai AS, Fraietta JA, Silverbush D, Chafamo D, Freeburg NF, et al. 静脉内双价CAR T细胞靶向EGFR和IL-13Rα2治疗复发性胶质母细胞瘤:一项1期临床试验。Nat Med. (2025). doi: 10.1038/s41591-025-03745-0

2025-06-010
PRE
cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classification

cIMPACT-NOW 更新 10:关于中枢神经系统肿瘤分类中新类型定义的建议

2025-05-260
OAAI
Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patients

弥漫性星形细胞瘤,AYA型,常伴MAPK通路改变:45例患者报告

2025-04-090
OA
The radiogenomic and spatiogenomic landscapes of glioblastoma and their relationship to oncogenic drivers
2025-03-010
OA
cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics

Cimact-NOW update 9: 关于利用全基因组DNA甲基化分析进行中枢神经系统肿瘤诊断的建议

2025-01-032
OA